#ivermectin for covid has been in heavy-play mode in the media again.
Why?
A new trial report, and 3 meta-analyses.
As usual, half the world thinks these are proof of the #ivermectincure and half thinks it's bogus.
Why can't we all get along?
@DrAndrewHill released his team's meta-analysis right on the heels of 2 other meta-analyses, one positive & one negative. Dr Hill, who has been a bit of an ivermectin cheerleader, had a positive conclusion: academic.oup.com/ofid/advance-a…
A huge concern w/ any meta-analysis is "Garbage In, Garbage Out" - and we've plenty of garbage in the IM world.
Whether a study rates inclusion and how it gets weighted in a meta-analysis can swing the conclusion.
These meta-analyses don't move the needle.
What about the new IVERCOR trial? bmcinfectdis.biomedcentral.com/articles/10.11…
Ivermectin proponents will point out that 1/3rd fewer of the treated patients developed severe disease;
doubters will observe the difference was not statistically significant.
This study had many of the same flaws we keep seeing.
Treatment protocol did not follow the most positive IM trials - dose was below the 12+mg level for avg adult, and avg treatment began 4d after symptoms.
SOONER is BETTER with ivermectin -- if it really works.
Then there's the randomization.
Another recurring theme.
The placebo group was a bit sicker than the ivermectin group.
Can having 8 more diabetic patients matter - when the outcome was 7 fewer people hospitalized?
Yes.
We are still left needing more information to weigh in on ivermectin with authority.
You'd think researchers would repeat the most compelling studies, to see if their findings can be reproduced.
This has not happened with the two studies that jump out as "compelling."
The HCW trials from Argentina - in which NO ONE who had IV/carrageenan prophylaxis developed covid while 58.2% of controls did, was just too good to be true.
But I can't see what went wrong with it.
It needs to be repeated! media.marinomed.com/8b/7a/c7/nota-…
And I love this study from Iran: clinicaltrials.gov/ProvidedDocs/6…
If you get past the mimeograph look to its trial design report, it's a clever way to rapidly investigate if IM works as exposure prophylaxis.
Control group was oddly high - 58% again - but IM group only 7% infection rate.
This trial begs to be repeated on a bigger budget.
That these are the strongest studies for IM - 58% vs 0%, 58% vs 7% - and both were exposure prophylaxis suggests that this is the angle to explore.
Western studies of IM for *treatment* have not done well.
So - when we will we "know" if ivermectin is effective vs covid?
We are promised that "large randomized trials" are underway which will "answer" the question.
Sadly, not.
The UK "PRINCIPLE", US "ACTIV-6," & Brazil/McMasters "TOGETHER," all allow enrollment 7-14d after diagnosis.
I suspect they will be negative, or marginal at best.
Ivermectin haters will have a field day.
Ivermectin fans will decry the poor study designs.
Dr Kory will continue to melt down in his anguish.
The whole scene is frustrating.
I continue to think there is some real but small chance ivermectin is effective vs covid, esp early in the course of exposure.
I'd like to see the question actually answered.
Much like mask efficacy, school closures, etc, I doubt we ever will.
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Another look at long covid out in a pre-print, from @mlipsitch&co: medrxiv.org/content/10.110…
I'm not surprised, but at last someone had the notion to compare folks post-covid to folks post-viral-infection, non-covid.
The headline is "14% had sequelae" but they buried the lede! 1/6
First, the limitations: 1) totally based, not on survey/exam, but on MD-reported ICD-10 codes; so these are "long," possibly random, symptoms bad enough to see an MD and have them code it. 2) retrospective cohort, so all the usual bias & matching concerns. 3) only age 18-65. 2/6
But it was HUGE (>200K matched cases), which helps;
and fairly well-matched;
and, at last, well-chosen cohorts (2020 no covid, 2019, pre-2020 viral).
WHAT DID THEY FIND???
Post-covid, you had a 14.6% chance of seeing an MD for post-viral problems.
Pre-2020 virus? 13%. 3/6
I am not terribly excited about the "clot" concerns for AZ/Ox in Europe: medscape.com/viewarticle/94…
Both because it's not in the US, and I didn't like their data or how they collected it very much;
and because I am not sure this is a story. 1/3
I mean, if the avg vaccinated pop would have about a 1/6000 risk per mo of a VTE as the background rate;
and 5M ppl got the AZ/Ox in the past mo;
we'd expect >800 VTEs in any circumstance, not 30! 2/3
Maybe the up side of this latest issue w/ the ill-fated AZ/Ox vaccine is for all the Vax-suspicious out there:
living proof that Big Pharma, Big Govt,etc isn't doing a very good job of "covering up" adverse events.
Arguably, they're swinging too far to the other extreme here! 3/3
I missed this disturbing/fascinating bit on leaked docs w/ quality control issues from the Pfizer vaccine: bmj.com/content/372/bm…
A reminder that just because Big Pharma hits a home run, they (& the medical-industrial complex) are not suddenly warm and fuzzy trusted friends. 1/3
I wish I understood mRNA vaccines better, but the bottom line appears to be:
these mRNA particles tucked in those lipid nanoparticle membranes are frail;
they degrade easily;
and you want them to be intact when they hit our cells, so the proper protein complexes are formed. 2/3
Since "commercial grade" seems to be 75-80% intact mRNA, and the "bad" batches were around 55%, that would imply about a third less production of proper spike-like proteins.
Not from zero to something, but from 25% to 45%.
So - I doubt these are forming *dangerous* proteins.
A few patients have asked me to look into the research on ivermectin for Covid-19.
You know, that video of congressional testimony and all, from that Pulmonologist.
IVERMECTIN SOUNDS FABULOUS! 1/20
Now, when I see a gray-haired, highly-confident, white dude speaking strongly on a matter outside his own field of expertise, I get this comfortable feeling:
"That is MY demographic!"
But when he goes on about his own credentials;
and calls a re-purposed med "miraculous"... 2/20
I get that skeptical feeling.
But - I'll try to put that aside, and just look at their data.
It's a lot to review.
These folks, the FRONT LINE COVID-19 CRITICAL CARE ALLIANCE, put out a 33 pg document summarizing the research on ivermectin and covid. 3/20